Gepefrine
| Gepefrine | |
|---|---|
| Molecular structure via molpic based on CDK |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 151.21 g/mol [1] |
| Predicted LogP | 1.4 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C9H13NO [1] |
| IUPAC name | 3-[(2S)-2-aminopropyl]phenol [1] |
| SMILES | C[C@@H](CC1=CC(=CC=C1)O)N [1] |
| InChI | InChI=1S/C9H13NO/c1-7(10)5-8-3-2-4-9(11)6-8/h2-4,6-7,11H,5,10H2,1H3/t7-/m0/s1 [1] |
| InChIKey | WTDGMHYYGNJEKQ-ZETCQYMHSA-N [1] |
(Redirected from 3-hydroxyamphetamine)
Gepefrine (also known as gepefrina, Gepefrin, Dtxsid60172191, α-Methyl-m-tyramine, gepefrinum, 3-hydroxyamphetamine, α-methyl-meta-tyramine, Dtxcid7094682, C01CA15 or 3-(2-Aminopropyl)phenol) is a sympathomimetic substance of the amphetamine class.
Chemistry
Stereochemistry []
Gepefrine is a absolute mixture.
Pharmacology
ATC Classification
In the cardiovascular system (C) gepefrine actsMetabolism
Subjective effects []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 219105, Gepefrine. Accessed May 6, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/219105
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Gepefrine. UNII: V51RRX51VH. Global Substance Registration System. Accessed May 6, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/V51RRX51VH